Impact of age on the management and prognosis of esophageal fistula after atrial fibrillation ablation-a subanalysis of the worldwide POTTER-AF study.
Options
BORIS DOI
Publisher DOI
PubMed ID
41756165
Description
Background
Esophageal fistula (EF) is a rare but devastating complication following atrial fibrillation (AF) ablation. Data regarding the impact of age on EF are scarce.
Objective
To study the impact of age on the management and prognosis of EF following catheter ablation for AF.
Methods
The POTTER-AF study is a worldwide registry on EF following catheter ablation for AF. A total of 553,729 patients underwent AF ablation in 214 centers between 1996 and 2022. Of them, 138 patients experienced EF, and data regarding age, management, and prognosis were available in 113 patients. The population was divided based on the median age.
Results
The median age was 63 years; 54 patients were <63 years old (Group 1), and 59 patients were ≥63 years old (Group 2). The groups were similar regarding procedural characteristics. The older population had a shorter time to symptom onset [15.0 (6.0, 21.0) vs. 21.0 (10.0, 25.3) days; p = 0.031]. Group 2 was less likely to receive a brain CT or MRI for diagnosis (25.9% vs. 45.3%; p = 0.046). The older population was more likely to undergo endoscopic treatment without surgery (27.6% vs. 11.3%; p = 0.035). Conservative and surgical treatments were used in similar proportions. A trend toward higher fatality was noted in the older patients (72.9% vs. 56.6%; p = 0.078).
Conclusion
The older population had a shorter time to symptom onset, was less likely to receive a brain CT or MRI, and more likely to be treated by an endoscopic approach only. The older patient group showed a trend toward a higher fatality.
Esophageal fistula (EF) is a rare but devastating complication following atrial fibrillation (AF) ablation. Data regarding the impact of age on EF are scarce.
Objective
To study the impact of age on the management and prognosis of EF following catheter ablation for AF.
Methods
The POTTER-AF study is a worldwide registry on EF following catheter ablation for AF. A total of 553,729 patients underwent AF ablation in 214 centers between 1996 and 2022. Of them, 138 patients experienced EF, and data regarding age, management, and prognosis were available in 113 patients. The population was divided based on the median age.
Results
The median age was 63 years; 54 patients were <63 years old (Group 1), and 59 patients were ≥63 years old (Group 2). The groups were similar regarding procedural characteristics. The older population had a shorter time to symptom onset [15.0 (6.0, 21.0) vs. 21.0 (10.0, 25.3) days; p = 0.031]. Group 2 was less likely to receive a brain CT or MRI for diagnosis (25.9% vs. 45.3%; p = 0.046). The older population was more likely to undergo endoscopic treatment without surgery (27.6% vs. 11.3%; p = 0.035). Conservative and surgical treatments were used in similar proportions. A trend toward higher fatality was noted in the older patients (72.9% vs. 56.6%; p = 0.078).
Conclusion
The older population had a shorter time to symptom onset, was less likely to receive a brain CT or MRI, and more likely to be treated by an endoscopic approach only. The older patient group showed a trend toward a higher fatality.
Date of Publication
2025
Publication Type
Article
Subject(s)
Keyword(s)
age
•
atrial fibrillation
•
catheter ablation
•
complication
•
esophageal fistula
Language(s)
en
Contributor(s)
Popescu, Sorin S | |
Demirtakan, Zeynep G | |
Schmidt, Vanessa | |
Pürerfellner, Helmut | |
Sommer, Philipp | |
Sohns, Christian | |
Veltmann, Christian | |
Steven, Daniel | |
Chun, K R Julian | |
Maury, Philippe | |
Gandjbakhch, Estelle | |
Laredo, Mikael | |
Willems, Stephan | |
Beiert, Thomas | |
Iden, Leon | |
Füting, Anna | |
Spittler, Raphael | |
Richter, Sergio | |
Schade, Anja | |
Kuniss, Malte | |
Wunderlich, Carsten | |
Shin, Dong-In | |
Grosse Meininghaus, Dirk | |
Bonsels, Marc | |
Reek, David | |
Wiegand, Uwe | |
Bauer, Alexander | |
Metzner, Andreas | |
Eckardt, Lars | |
Krahnefeld, Olaf | |
Sticherling, Christian | |
Kühne, Michael | |
Nguyen, Dinh Quang | |
Linz, Dominik | |
van der Voort, Pepijn | |
Mulder, Bart A | |
Vijgen, Johan | |
Almorad, Alexandre | |
Guenancia, Charles | |
Fauchier, Laurent | |
Boveda, Serge | |
De Greef, Yves | |
Da Costa, Antoine | |
Jais, Pierre | |
Milhem, Antoine | |
Jesel, Laurence | |
Poty, Hervé | |
Khoueiry, Ziad | |
Seitz, Julien | |
Laborderie, Julien | |
Mechulan, Alexis | |
Brigadeau, Francois | |
Zhao, Alexandre | |
Saludas, Yannick | |
Ahluwalia, Nikhil | |
Martin, Claire | |
Chen, Jian | |
Antolic, Bor | |
Leventopoulos, Georgios | |
Özcan, Emin Evren | |
Yorgun, Hikmet | |
Cay, Serkan | |
Yalin, Kivanc | |
Sobhy Botros, Maichel | |
Jędrzejczyk-Patej, Ewa | |
Inaba, Osamu | |
Okumura, Ken | |
Ejima, Koichiro | |
Khakpour, Houman | |
Catanzaro, John N | |
Reddy, Vivek | |
Natale, Andrea | |
Blessberger, Hermann | |
Yang, Bing | |
Kuck, Karl-Heinz | |
Merino, José Luis | |
Keelani, Ahmad | |
Heeger, Christian-H | |
Tilz, Roland Richard |
Additional Credits
Series
Frontiers in Cardiovascular Medicine
Publisher
Frontiers Media
ISSN
2297-055X
Access(Rights)
open.access